Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sugo

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Nihon Sanka Fujinka Gakkai Zasshi|June 1, 1993
[A case of uterine cystic adenomyoma]Y Yokoyama, T Sugo, T Higuchi, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia AS Madoiwa, T Yamauchi, Y Hakamata, et al.
European Journal of Pharmacology|May 1, 1997
Antagonist activity of [Thr18,gamma-methylleucine19]endothelin-1 in human endothelin receptorsY Masuda, T Sugo, T Kikuchi, et al.
Blood|December 15, 1993
Fibrinogen Mitaka II: a hereditary dysfibrinogen with defective thrombin binding caused by an A alpha Glu-11 to Gly substitutionK Niwa, A Yaginuma, M Nakanishi, et al.
International Journal of Hematology|October 1, 1993
Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individualsS Nomura, Y Komiyama, T Murakami, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine Factor XIIH Kato, T Sugo, N Ikari, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptorsY Masuda, T Sugo, T Kikuchi, et al.
Analytical Chemistry|October 17, 2002
Concentration of 17beta-estradiol using an immunoaffinity porous hollow-fiber membraneS Nishiyama, A Goto, K Saito, et al.
Thrombosis and Haemostasis|September 1, 1993
A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healingY Wada, K Niwa, H Maekawa, et al.
Blood|November 23, 2000
End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extension lead to fragile clot structureT Sugo, C Nakamikawa, N Yoshida, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Nihon Sanka Fujinka Gakkai Zasshi|June 1, 1993
[A case of uterine cystic adenomyoma]Y Yokoyama, T Sugo, T Higuchi, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia AS Madoiwa, T Yamauchi, Y Hakamata, et al.
European Journal of Pharmacology|May 1, 1997
Antagonist activity of [Thr18,gamma-methylleucine19]endothelin-1 in human endothelin receptorsY Masuda, T Sugo, T Kikuchi, et al.
Blood|December 15, 1993
Fibrinogen Mitaka II: a hereditary dysfibrinogen with defective thrombin binding caused by an A alpha Glu-11 to Gly substitutionK Niwa, A Yaginuma, M Nakanishi, et al.
International Journal of Hematology|October 1, 1993
Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individualsS Nomura, Y Komiyama, T Murakami, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine Factor XIIH Kato, T Sugo, N Ikari, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptorsY Masuda, T Sugo, T Kikuchi, et al.
Analytical Chemistry|October 17, 2002
Concentration of 17beta-estradiol using an immunoaffinity porous hollow-fiber membraneS Nishiyama, A Goto, K Saito, et al.
Thrombosis and Haemostasis|September 1, 1993
A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healingY Wada, K Niwa, H Maekawa, et al.
Blood|November 23, 2000
End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extension lead to fragile clot structureT Sugo, C Nakamikawa, N Yoshida, et al.
Pageof 8